Page 55 - OR-1-1

4.6. Assembloid complex disease models, and advance the development of
Assembloids represent a cutting-edge, rapidly evolving personalized medicine. By combining multiple organoid
technology in organoid research, involving the fusion of types, assembloids create more biologically relevant
multiple organoid cultures derived from different tissues models that reflect the complexity of human biology and
to create more complex, multi-tissue constructs. These diseases, providing a platform for innovative therapeutic
assembloids offer a more sophisticated and dynamic interventions.
representation of human biology compared to traditional 5. Expanding therapeutic horizons with
single-organ models. By combining organoids from diverse
tissues, such as the brain, heart, liver, and gut, assembloids organoids
enable the study of inter-organ communication, tissue 5.1. Organoid-based drug discovery and screening
crosstalk, and systemic responses in a way that mirrors
the human body’s intricate network of organs and organ One of the most promising applications of organoids in
systems. This innovation allows researchers to investigate therapeutics is their use in drug discovery and screening.
how organs influence one another’s functions, which is Traditional drug testing methods, such as 2D cell cultures
essential for understanding multi-organ diseases, cancer and animal models, often fail to replicate the complexity
metastasis, neurodegeneration, and other pathologies that of human tissues, leading to limitations in drug efficacy
involve multiple systems. 97,98 and safety predictions. Organoids, which closely resemble
human tissues in structure and function, offer a more
A key advantage of assembloid technology is its ability to accurate and scalable alternative for screening potential
simulate complex tissue interactions and mimic the spatial drug candidates. 105
organization seen in vivo. For example, assembloids made
from gut-liver models can mimic the gut-liver axis, which By using patient-derived organoids (PDOs), researchers
is crucial for studying processes, such as drug metabolism, can test the effects of a wide range of drug compounds
99
nutrient absorption, and inflammatory responses. These on individual patients’ tissues, providing a personalized
multi-organoid systems can provide an unprecedented approach to medicine. This not only enhances drug efficacy
understanding of disease progression by highlighting but also minimizes adverse effects by identifying potential
106
tissue-specific events and revealing the cross-talk between toxicities at an early stage. In addition, organoids can be
different tissue types that drive pathophysiological employed to evaluate drug responses in disease-specific
processes. 100,101 models, such as cancer or neurodegenerative diseases,
enabling the discovery of novel therapeutics tailored to
In addition to disease modeling, assembloid technology 107
has applications in drug discovery and testing, as it allows for specific conditions.
the assessment of the effects of pharmaceutical compounds In cancer research, the application of organoid
on multiple organs simultaneously. This approach could technology has been particularly prominent. For instance,
lead to more effective drug screening, reducing the need for researchers can utilize patient-derived tumor organoids
animal models and increasing the precision and relevance (PDTOs) to model tumor growth and drug responses. 108-110
of the results obtained. Moreover, assembloids can be These PDTOs retain the genetic and phenotypic
102
used for personalized medicine, as they can be generated characteristics of the original tumors, providing a more
from patient-specific cells, allowing for the testing of drugs accurate model for cancer treatment. By testing various
or therapies tailored to an individual’s genetic and cellular anticancer drugs on PDTOs, researchers can rapidly
makeup. 103 identify effective drug combinations for specific patients,
The integration of assembloids with other emerging thereby offering a foundation for personalized therapy. 111
technologies, such as microfluidics, bioelectronics, and In the study of neurodegenerative diseases, organoids
gene editing, further enhances their potential. Microfluidic also demonstrate significant potential. For example,
systems can be used to precisely control the flow of fluids researchers can employ brain organoids to simulate
and nutrients to the assembloid cultures, mimicking the pathological processes of diseases such as Alzheimer’s and
physiological environment of human organs. Similarly, Parkinson’s. 112,113 These brain organoids can recapitulate
gene-editing technologies can be used to introduce disease- disease-associated neurodegenerative changes, serving as
specific mutations into the assembloids, providing more powerful tools for investigating disease mechanisms and
accurate disease models that can be used for drug discovery screening potential therapeutic compounds. By testing
and personalized treatment strategies. 104 different drugs on these disease models, researchers can gain
In summary, assembloid technology represents a a deeper understanding of drug mechanisms and discover
significant leap forward in organoid research, offering novel therapies targeting specific neurodegenerative
the ability to study multi-organ interactions, simulate disorders.

Volume 1 Issue 1 (2025) 8 doi: 10.36922/OR025040007